PRLog - Apr. 26, 2012 - MACOMB, Mich. -- (MACOMB, MICHIGAN) – HyProCure®, an extra-osseous talotarsal stabilization (EOTTS) device made by GraMedica®, a global orthopedic medical device company, is increasingly recognized worldwide as the premier treatment option for talotarsal dislocation. In a recent publication from The International Federation of Podiatrists (FIP), HyProCure® was distinguished as the only EOTTS device proven to restore the normal alignment of the articular facets of the talotarsal joint, thus eliminating abnormal excessive motion while preserving the normal range of motion. Dr. Bryan Bullard of Amarillo, TX, USA, described the evidence-based research behind EOTTS with HyProCure® and said it “is an incredibly powerful technique which should be in the armamentarium of any foot and ankle surgeon which deals with the life changing complications associated with chronic talotarsal dislocation.”
In the article, Bryan P. Bullard, DPM, Fellow, ACFAS, Fellow, AENS, provided the background on treatment options available for a mal-alignment of the talus on the tarsal mechanism. He noted that conservative treatment options and traditional surgical options have many limitations. Bullard then addressed how the HyProCure® EOTTS device “overcomes many of the limitations of earlier devices.”
FIP works to advance podiatry worldwide through education, advocacy and strategic alliances for the benefit of those with foot and ankle ailments. The Federation was founded in 1947 with 10 podiatry organizations. Over the years, it has grown to include 31 organizations representing 30 countries spread over six continents. “Having EOTTS with HyProCure® as a topic in FIP’s quarterly news is an honor and motivates us to continue to work to provide life-changing solutions to patients worldwide,” said Michael E. Graham, President and Founder of GraMedica®, and creator of HyProCure®.
GraMedica® provides a revolutionary extra-osseous talotarsal stabilization device that is placed inside the foot via a minimally invasive, out-patient procedure. HyProCure® resolves the root cause of the flexible deformity and restores proper foot mechanics. As a result of anatomically correcting the foot, the alignment of the rest of the body is restored and symptoms in other parts of the body are gradually improved and often completely eliminated. HyProCure® represents a real solution for patients suffering from this condition. It has been used by foot surgeons since 2004.
Potential surgical candidates can find out more about the HyProCure® solution and the devastating effects of talotarsal dislocation at http://www.HyProCure.com. Find a local HyProCure® specialist through the physician locator at http://www.HyProCure.com/
Foot and ankle surgeons are invited to learn more about the HyProCure® implant and procedure at http://www.GraMedica.com, where they can also train online and/or find a live surgical training seminar in their area.
Learn more about HyProCure® and osteo-WEDGE™, GraMedica®’s latest innovative Bone Locking System at www.GraMedica.com;
GraMedica® is a global orthopedic medical device company and leader in foot care solutions. Recognized for its innovation, the company is producer of breakthrough products like HyProCure® and osteo-WEDGE™.
Susan Doherty, Director, Education & Physician Resources